Reports for TEVA CANADA LIMITED
Company Name
TEVA CANADA LIMITED
Totals |
||
Shortage reports |
3187 |
|
| Actual shortage: | 257 (8%) | |
| Anticipated shortage: | 1 (0%) | |
| Avoided shortage: | 10 (0%) | |
| Resolved: | 2919 (92%) | |
Discontinuation Reports |
435 |
|
| To be discontinued: | 2 (0%) | |
| Discontinued: | 410 (94%) | |
| Reversed: | 23 (5%) | |
Late reports |
482 (13%) |
|
Overdue reports |
12 (5%) |
|
Shortage reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| TEVA-BUPROPION XL | 300MG | TABLET (EXTENDED-RELEASE) | Resolved | 2023-11-09 | 2023-12-07 | 209672 |
| TEVA-BUPROPION XL | 150MG | TABLET (EXTENDED-RELEASE) | Resolved | 2024-01-11 | 2024-02-22 | 215743 |
| TEVA-BUPROPION XL | 300MG | TABLET (EXTENDED-RELEASE) | Resolved | 2024-01-11 | 2024-02-22 | 215746 |
| TEVA-BUPROPION XL | 300MG | TABLET (EXTENDED-RELEASE) | Resolved | 2024-03-28 | 2024-06-07 | 223856 |
| TEVA-BUPROPION XL | 300MG | TABLET (EXTENDED-RELEASE) | Resolved | 2024-04-05 | 2024-06-07 | 224445 |
| TEVA-BUPROPION XL | 150MG | TABLET (EXTENDED-RELEASE) | Resolved | 2024-04-18 | 2024-05-16 | 225492 |
| TEVA-BUPROPION XL | 300MG | TABLET (EXTENDED-RELEASE) | Resolved | 2024-06-20 | 2025-01-30 | 230958 |
| TEVA-BUPROPION XL | 150MG | TABLET (EXTENDED-RELEASE) | Resolved | 2024-06-20 | 2025-02-06 | 230961 |
| TEVA-BUPROPION XL | 150MG | TABLET (EXTENDED-RELEASE) | Resolved | 2024-07-11 | 2025-02-20 | 232747 |
| TEVA-BUPROPION XL | 300MG | TABLET (EXTENDED-RELEASE) | Resolved | 2025-01-23 | 2025-03-04 | 248445 |
| TEVA-BUPROPION XL | 150MG | TABLET (EXTENDED-RELEASE) | Resolved | 2025-02-20 | 2025-03-27 | 250909 |
| TEVA-BUSPIRONE | 10MG | TABLET | Resolved | 2019-06-18 | 2019-07-15 | 86846 |
| TEVA-BUSPIRONE | 10MG | TABLET | Resolved | 2021-03-25 | 2021-04-01 | 136314 |
| TEVA-BUSPIRONE | 10MG | TABLET | Resolved | 2021-04-29 | 2021-05-13 | 138294 |
| TEVA-BUSPIRONE | 10MG | TABLET | Resolved | 2022-02-17 | 2022-03-24 | 155152 |
| TEVA-BUSPIRONE | 10MG | TABLET | Resolved | 2024-04-25 | 2025-03-13 | 226174 |
| TEVA-BUSPIRONE | 10MG | TABLET | Resolved | 2024-06-07 | 2025-04-28 | 229945 |
| TEVA-BUSPIRONE | 10MG | TABLET | Actual shortage | 2025-11-20 | 2025-11-20 | 272295 |
| TEVA-CANDESARTAN | 16MG | TABLET | Resolved | 2019-06-27 | 2019-11-01 | 87690 |
| TEVA-CANDESARTAN | 16MG | TABLET | Resolved | 2019-08-22 | 2019-11-01 | 92192 |
Discontinuation reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| ACT ENALAPRIL | 8MG | TABLET | Discontinued | 2025-05-28 | 2025-05-28 | 258676 |
| ACT ENALAPRIL | 4MG | TABLET | Discontinued | 2025-05-28 | 2025-05-28 | 258682 |
| ACT ESCITALOPRAM | Discontinued | 2018-10-17 | 2018-10-17 | 64520 | ||
| ACT ESCITALOPRAM | Discontinued | 2018-10-17 | 2018-10-17 | 64526 | ||
| ACT ESCITALOPRAM | Discontinued | 2018-10-17 | 2018-10-17 | 64529 | ||
| ACT ESCITALOPRAM | Discontinued | 2018-10-17 | 2018-10-17 | 64532 | ||
| ACT ESCITALOPRAM | Discontinued | 2018-10-17 | 2018-10-17 | 64535 | ||
| ACT ETIDROCAL | 400MG 500MG | TABLET | Discontinued | 2019-02-21 | 2019-03-01 | 76486 |
| ACT FLUCONAZOLE | 50MG | TABLET | Discontinued | 2025-05-28 | 2025-05-28 | 258697 |
| ACT FLUCONAZOLE | 100MG | TABLET | Discontinued | 2025-05-28 | 2025-05-28 | 258703 |
| TEVA-LEVETIRACETAM | 500MG | TABLET | Discontinued | 2020-01-24 | 2020-01-24 | 104304 |
| TEVA-LEVOFLOXACIN | 250MG | TABLET | Discontinued | 2025-09-02 | 2025-09-02 | 266377 |
| TEVA-LEVOFLOXACIN | 500MG | TABLET | Discontinued | 2025-09-02 | 2025-09-02 | 266380 |
| TEVA-LEVOFLOXACIN | 750MG | TABLET | Discontinued | 2025-09-02 | 2025-09-02 | 266383 |
| ACT NABILONE | 1MG | CAPSULE | Discontinued | 2019-10-31 | 2019-11-01 | 97581 |
| ACT NABILONE | 0.5MG | CAPSULE | Discontinued | 2020-10-15 | 2020-10-15 | 126452 |
| ACT NABILONE | 0.5MG | CAPSULE | Discontinued | 2021-09-23 | 2021-09-23 | 146066 |
| ACT OLANZAPINE ODT | 5MG | TABLET (ORALLY DISINTEGRATING) | Discontinued | 2019-10-25 | 2019-10-26 | 97256 |
| ACT OLANZAPINE ODT | 15MG | TABLET (ORALLY DISINTEGRATING) | Discontinued | 2020-01-24 | 2020-01-24 | 104277 |
| TEVA-OLMESARTAN | 20MG | TABLET | Discontinued | 2020-06-11 | 2020-06-11 | 117497 |